论文部分内容阅读
[目的]观察痛风定、益肾蠲痹丸联合西药治疗类风湿性关节炎疗效。[方法]使用随机平行对照方法,将100例住院患者按抛硬币法简单随机分为两组。对照组50例来氟米特20mg/次,1次/d;塞来昔布0.2g/次,1次/d;甲氨蝶呤10mg/次,7d/次。治疗组50例痛风定1.6g/次,3次/d;益肾蠲痹丸12g/次,3次/d;疼痛减轻后可适量调整用药量,停用塞来昔布,酌情减少益肾蠲痹丸和痛风定用量;西药治疗同对照组。连续治疗24周为1疗程。观测临床症状、类风湿因子、血沉、不良反应。治疗1疗程,判定疗效。[结果]治疗组近期控制21例,显效26例,有效22例,无效2例,总有效率96.00%。对照组近期控制7例,显效21例,有效11例,无效11例,总有效率78.00%。治疗组疗效优于对照组(P<0.05)。[结论]痛风定、益肾蠲痹丸联合西药联合西药治疗类风湿性关节炎效果显著,值得推广。
[Objective] To observe the curative effect of Tongfeng Ding, Yishen Tiabi Pill combined with Western medicine on rheumatoid arthritis. [Methods] Using randomized parallel control method, 100 inpatients were randomly divided into two groups according to the coin-tossing method. The control group, 50 cases of leflunomide 20mg / time, 1 / d; celecoxib 0.2g / time, 1 / d; methotrexate 10mg / time, 7d / time. The treatment group, 50 cases of gout set at 1.6g / time, 3 times / d; Yishen Junbi pill 12g / time, 3 times / d; pain relief can be appropriate to adjust the dosage, discontinued celecoxib, as appropriate to reduce kidney Bi Bi pills and gout fixed amount; western medicine treatment with the control group. Continuous treatment for 24 weeks for a course of treatment. Observation of clinical symptoms, rheumatoid factor, erythrocyte sedimentation rate, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] The treatment group recently controlled 21 cases, markedly effective in 26 cases, effective in 22 cases, ineffective in 2 cases, the total effective rate was 96.00%. The control group recently controlled 7 cases, 21 cases markedly effective in 11 cases, ineffective in 11 cases, the total effective rate 78.00%. The treatment group was better than the control group (P <0.05). [Conclusion] Tongfengding, Yishen Tiabi Pill combined with western medicine and western medicine have significant effect on rheumatoid arthritis and worthy of promotion.